APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tianeptine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tianeptine Industry Growth and Trends Forecast to 2032

Report ID 174041200119 December 2025114 pages

Choose your research edition.

Industry ResearchTianeptine Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Tianeptine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Tianeptine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tianeptine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Tianeptine Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Tianeptine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tianeptine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tianeptine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tianeptine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tianeptine include Adamed, Alvogen, Antibiotice, Arena Pharmaceuticals, Bausch Health, Dongwha Pharm, Genefar B.V., Glenmark and Grupo Insud, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tianeptine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tianeptine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tianeptine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tianeptine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tianeptine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tianeptine Market by Company

Adamed

Alvogen

Antibiotice

Arena Pharmaceuticals

Bausch Health

Dongwha Pharm

Genefar B.V.

Glenmark

Grupo Insud

Liconsa SA

Lupin Limited

neuraxpharm Arzneimittel

PharmaS

Serdia Pharmaceuticals

Servier

Mylan

Novartis

Tianeptine Segment by Type

Patent

Generic

Tianeptine Segment by Application

Depression and Anxiety

Irritable Bowel Syndrome

Tianeptine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tianeptine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tianeptine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tianeptine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tianeptine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tianeptine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Patent Table 2. Major Company of Generic Table 3. Global Tianeptine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tianeptine Sales by Type (2021-2026) & (K Units) Table 5. Global Tianeptine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tianeptine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tianeptine Sales Market Share in Value by Type (2021-2026) Table 8. Global Tianeptine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tianeptine Sales by Type (2027-2032) & (K Units) Table 10. Global Tianeptine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tianeptine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tianeptine Sales Market Share in Value by Type (2027-2032) Table 13. Global Tianeptine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tianeptine Sales by Type (2021-2026) & (K Units) Table 15. North America Tianeptine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tianeptine Sales by Type (2021-2026) & (K Units) Table 17. Europe Tianeptine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tianeptine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tianeptine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tianeptine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tianeptine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tianeptine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tianeptine Sales by Type (2021-2026) & (US$ Million) Table 24. Tianeptine Industry Trends Table 25. Tianeptine Industry Drivers Table 26. Tianeptine Industry Opportunities and Challenges Table 27. Tianeptine Industry Restraints Table 28. Global Tianeptine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tianeptine Revenue Market Share by Company (2021-2026) Table 30. Global Tianeptine Sales by Company (2021-2026) & (K Units) Table 31. Global Tianeptine Sales Share by Company (2021-2026) Table 32. Global Tianeptine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tianeptine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tianeptine Major Company Production Sites and Headquarters Table 35. Global Tianeptine Company, Product Type & Application Table 36. Global Tianeptine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tianeptine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tianeptine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tianeptine Sales by Region (2021-2026) & (K Units) Table 41. Global Tianeptine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tianeptine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tianeptine Sales Market Share in Value by Region (2021-2026) Table 44. Global Tianeptine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tianeptine Sales by Region (2027-2032) & (K Units) Table 46. Global Tianeptine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tianeptine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tianeptine Sales Market Share in Value by Region (2027-2032) Table 49. Global Tianeptine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tianeptine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tianeptine Sales by Application (2021-2026) & (K Units) Table 52. Global Tianeptine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tianeptine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tianeptine Sales Market Share in Value by Application (2021-2026) Table 55. Global Tianeptine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tianeptine Sales by Application (2027-2032) & (K Units) Table 57. Global Tianeptine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tianeptine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tianeptine Sales Market Share in Value by Application (2027-2032) Table 60. Global Tianeptine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tianeptine Sales by Application (2021-2026) & (K Units) Table 62. North America Tianeptine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tianeptine Sales by Application (2021-2026) & (K Units) Table 64. Europe Tianeptine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tianeptine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tianeptine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tianeptine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tianeptine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tianeptine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tianeptine Sales by Application (2021-2026) & (US$ Million) Table 71. Adamed Company Information Table 72. Adamed Business Overview Table 73. Adamed Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Adamed Tianeptine Product Portfolio Table 75. Adamed Recent Development Table 76. Alvogen Company Information Table 77. Alvogen Business Overview Table 78. Alvogen Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Alvogen Tianeptine Product Portfolio Table 80. Alvogen Recent Development Table 81. Antibiotice Company Information Table 82. Antibiotice Business Overview Table 83. Antibiotice Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Antibiotice Tianeptine Product Portfolio Table 85. Antibiotice Recent Development Table 86. Arena Pharmaceuticals Company Information Table 87. Arena Pharmaceuticals Business Overview Table 88. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Arena Pharmaceuticals Tianeptine Product Portfolio Table 90. Arena Pharmaceuticals Recent Development Table 91. Bausch Health Company Information Table 92. Bausch Health Business Overview Table 93. Bausch Health Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bausch Health Tianeptine Product Portfolio Table 95. Bausch Health Recent Development Table 96. Dongwha Pharm Company Information Table 97. Dongwha Pharm Business Overview Table 98. Dongwha Pharm Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Dongwha Pharm Tianeptine Product Portfolio Table 100. Dongwha Pharm Recent Development Table 101. Genefar B.V. Company Information Table 102. Genefar B.V. Business Overview Table 103. Genefar B.V. Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Genefar B.V. Tianeptine Product Portfolio Table 105. Genefar B.V. Recent Development Table 106. Glenmark Company Information Table 107. Glenmark Business Overview Table 108. Glenmark Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Glenmark Tianeptine Product Portfolio Table 110. Glenmark Recent Development Table 111. Grupo Insud Company Information Table 112. Grupo Insud Business Overview Table 113. Grupo Insud Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Grupo Insud Tianeptine Product Portfolio Table 115. Grupo Insud Recent Development Table 116. Liconsa SA Company Information Table 117. Liconsa SA Business Overview Table 118. Liconsa SA Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Liconsa SA Tianeptine Product Portfolio Table 120. Liconsa SA Recent Development Table 121. Lupin Limited Company Information Table 122. Lupin Limited Business Overview Table 123. Lupin Limited Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Lupin Limited Tianeptine Product Portfolio Table 125. Lupin Limited Recent Development Table 126. neuraxpharm Arzneimittel Company Information Table 127. neuraxpharm Arzneimittel Business Overview Table 128. neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. neuraxpharm Arzneimittel Tianeptine Product Portfolio Table 130. neuraxpharm Arzneimittel Recent Development Table 131. PharmaS Company Information Table 132. PharmaS Business Overview Table 133. PharmaS Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. PharmaS Tianeptine Product Portfolio Table 135. PharmaS Recent Development Table 136. Serdia Pharmaceuticals Company Information Table 137. Serdia Pharmaceuticals Business Overview Table 138. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Serdia Pharmaceuticals Tianeptine Product Portfolio Table 140. Serdia Pharmaceuticals Recent Development Table 141. Servier Company Information Table 142. Servier Business Overview Table 143. Servier Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Servier Tianeptine Product Portfolio Table 145. Servier Recent Development Table 146. Mylan Company Information Table 147. Mylan Business Overview Table 148. Mylan Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Mylan Tianeptine Product Portfolio Table 150. Mylan Recent Development Table 151. Novartis Company Information Table 152. Novartis Business Overview Table 153. Novartis Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Novartis Tianeptine Product Portfolio Table 155. Novartis Recent Development Table 156. North America Tianeptine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Tianeptine Sales by Country (2021-2026) & (K Units) Table 158. North America Tianeptine Sales Market Share by Country (2021-2026) Table 159. North America Tianeptine Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Tianeptine Sales Market Share Forecast by Country (2027-2032) Table 161. North America Tianeptine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Tianeptine Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Tianeptine Market Share by Country (2021-2026) Table 164. North America Tianeptine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Tianeptine Market Share Forecast by Country (2027-2032) Table 166. Europe Tianeptine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Tianeptine Sales by Country (2021-2026) & (K Units) Table 168. Europe Tianeptine Sales Market Share by Country (2021-2026) Table 169. Europe Tianeptine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Tianeptine Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Tianeptine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Tianeptine Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Tianeptine Market Share by Country (2021-2026) Table 174. Europe Tianeptine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Tianeptine Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Tianeptine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Tianeptine Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Tianeptine Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Tianeptine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Tianeptine Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Tianeptine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Tianeptine Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Tianeptine Market Share by Country (2021-2026) Table 184. Asia-Pacific Tianeptine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Tianeptine Market Share Forecast by Country (2027-2032) Table 186. Latin America Tianeptine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Tianeptine Sales by Country (2021-2026) & (K Units) Table 188. Latin America Tianeptine Sales Market Share by Country (2021-2026) Table 189. Latin America Tianeptine Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Tianeptine Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Tianeptine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Tianeptine Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Tianeptine Market Share by Country (2021-2026) Table 194. Latin America Tianeptine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Tianeptine Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Tianeptine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Tianeptine Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Tianeptine Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Tianeptine Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Tianeptine Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Tianeptine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Tianeptine Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Tianeptine Market Share by Country (2021-2026) Table 204. Middle East and Africa Tianeptine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Tianeptine Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Tianeptine Distributors List Table 209. Tianeptine Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Tianeptine Image Figure 2. Global Tianeptine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tianeptine Market Size (2021-2032) & (US$ Million) Figure 4. Global Tianeptine Sales (2021-2032) & (K Units) Figure 5. Patent Image Figure 6. Global Patent Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Image Figure 8. Global Generic Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tianeptine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tianeptine Market Share by Type 2025 VS 2032 Figure 11. North America Tianeptine Sales Market Share in Volume by Type in 2025 Figure 12. North America Tianeptine Sales Market Share in Value by Type in 2025 Figure 13. Europe Tianeptine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tianeptine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tianeptine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tianeptine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tianeptine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tianeptine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tianeptine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tianeptine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tianeptine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Depression and Anxiety Image Figure 24. Global Depression and Anxiety Sales YoY Growth (2021-2032) & (K Units) Figure 25. Irritable Bowel Syndrome Image Figure 26. Global Irritable Bowel Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Tianeptine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Tianeptine Market Share by Application 2025 VS 2032 Figure 29. North America Tianeptine Sales Market Share in Volume by Application in 2025 Figure 30. North America Tianeptine Sales Market Share in Value by Application in 2025 Figure 31. Europe Tianeptine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Tianeptine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Tianeptine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Tianeptine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Tianeptine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Tianeptine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Tianeptine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Tianeptine Sales Market Share in Value by Application in 2025 Figure 39. North America Tianeptine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Tianeptine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Tianeptine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Tianeptine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Tianeptine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Tianeptine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tianeptine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Tianeptine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Tianeptine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Tianeptine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tianeptine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Tianeptine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Tianeptine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Tianeptine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tianeptine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Tianeptine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Tianeptine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Tianeptine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tianeptine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Tianeptine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Tianeptine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Tianeptine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • Depression and Anxiety
  • Irritable Bowel Syndrome
Companies covered
  • Adamed
  • Alvogen
  • Antibiotice
  • Arena Pharmaceuticals
  • Bausch Health
  • Dongwha Pharm
  • Genefar B.V.
  • Glenmark
  • Grupo Insud
  • Liconsa SA
  • Lupin Limited
  • neuraxpharm Arzneimittel
  • PharmaS
  • Serdia Pharmaceuticals
  • Servier
  • Mylan
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tianeptine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tianeptine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tianeptine Market by Type
  6. 1.3.1 Patent
  7. 1.3.2 Generic
  8. 1.4 Global Tianeptine Market Size by Type
  9. 1.4.1 Global Tianeptine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tianeptine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tianeptine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tianeptine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tianeptine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tianeptine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tianeptine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tianeptine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tianeptine Industry Trends
  2. 2.2 Tianeptine Industry Drivers
  3. 2.3 Tianeptine Industry Opportunities and Challenges
  4. 2.4 Tianeptine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tianeptine Revenue (2021-2026)
  2. 3.2 Global Top Players by Tianeptine Sales (2021-2026)
  3. 3.3 Global Top Players by Tianeptine Price (2021-2026)
  4. 3.4 Global Tianeptine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tianeptine Major Company Production Sites & Headquarters
  6. 3.6 Global Tianeptine Company, Product Type & Application
  7. 3.7 Global Tianeptine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tianeptine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tianeptine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tianeptine Tier 1, Tier 2, and Tier 3
4 Tianeptine Regional Status and Outlook
  1. 4.1 Global Tianeptine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tianeptine Historic Market Size by Region
  3. 4.2.1 Global Tianeptine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tianeptine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tianeptine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tianeptine Forecasted Market Size by Region
  7. 4.3.1 Global Tianeptine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tianeptine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tianeptine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tianeptine by Application
  1. 5.1 Tianeptine Market by Application
  2. 5.1.1 Depression and Anxiety
  3. 5.1.2 Irritable Bowel Syndrome
  4. 5.2 Global Tianeptine Market Size by Application
  5. 5.2.1 Global Tianeptine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Tianeptine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Tianeptine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Tianeptine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Tianeptine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Tianeptine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Tianeptine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Tianeptine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Adamed
  2. 6.1.1 Adamed Company Information
  3. 6.1.2 Adamed Business Overview
  4. 6.1.3 Adamed Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Adamed Tianeptine Product Portfolio
  6. 6.1.5 Adamed Recent Developments
  7. 6.2 Alvogen
  8. 6.2.1 Alvogen Company Information
  9. 6.2.2 Alvogen Business Overview
  10. 6.2.3 Alvogen Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Alvogen Tianeptine Product Portfolio
  12. 6.2.5 Alvogen Recent Developments
  13. 6.3 Antibiotice
  14. 6.3.1 Antibiotice Company Information
  15. 6.3.2 Antibiotice Business Overview
  16. 6.3.3 Antibiotice Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Antibiotice Tianeptine Product Portfolio
  18. 6.3.5 Antibiotice Recent Developments
  19. 6.4 Arena Pharmaceuticals
  20. 6.4.1 Arena Pharmaceuticals Company Information
  21. 6.4.2 Arena Pharmaceuticals Business Overview
  22. 6.4.3 Arena Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Arena Pharmaceuticals Tianeptine Product Portfolio
  24. 6.4.5 Arena Pharmaceuticals Recent Developments
  25. 6.5 Bausch Health
  26. 6.5.1 Bausch Health Company Information
  27. 6.5.2 Bausch Health Business Overview
  28. 6.5.3 Bausch Health Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bausch Health Tianeptine Product Portfolio
  30. 6.5.5 Bausch Health Recent Developments
  31. 6.6 Dongwha Pharm
  32. 6.6.1 Dongwha Pharm Company Information
  33. 6.6.2 Dongwha Pharm Business Overview
  34. 6.6.3 Dongwha Pharm Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dongwha Pharm Tianeptine Product Portfolio
  36. 6.6.5 Dongwha Pharm Recent Developments
  37. 6.7 Genefar B.V.
  38. 6.7.1 Genefar B.V. Company Information
  39. 6.7.2 Genefar B.V. Business Overview
  40. 6.7.3 Genefar B.V. Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Genefar B.V. Tianeptine Product Portfolio
  42. 6.7.5 Genefar B.V. Recent Developments
  43. 6.8 Glenmark
  44. 6.8.1 Glenmark Company Information
  45. 6.8.2 Glenmark Business Overview
  46. 6.8.3 Glenmark Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Glenmark Tianeptine Product Portfolio
  48. 6.8.5 Glenmark Recent Developments
  49. 6.9 Grupo Insud
  50. 6.9.1 Grupo Insud Company Information
  51. 6.9.2 Grupo Insud Business Overview
  52. 6.9.3 Grupo Insud Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Grupo Insud Tianeptine Product Portfolio
  54. 6.9.5 Grupo Insud Recent Developments
  55. 6.10 Liconsa SA
  56. 6.10.1 Liconsa SA Company Information
  57. 6.10.2 Liconsa SA Business Overview
  58. 6.10.3 Liconsa SA Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Liconsa SA Tianeptine Product Portfolio
  60. 6.10.5 Liconsa SA Recent Developments
  61. 6.11 Lupin Limited
  62. 6.11.1 Lupin Limited Company Information
  63. 6.11.2 Lupin Limited Business Overview
  64. 6.11.3 Lupin Limited Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lupin Limited Tianeptine Product Portfolio
  66. 6.11.5 Lupin Limited Recent Developments
  67. 6.12 neuraxpharm Arzneimittel
  68. 6.12.1 neuraxpharm Arzneimittel Company Information
  69. 6.12.2 neuraxpharm Arzneimittel Business Overview
  70. 6.12.3 neuraxpharm Arzneimittel Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 neuraxpharm Arzneimittel Tianeptine Product Portfolio
  72. 6.12.5 neuraxpharm Arzneimittel Recent Developments
  73. 6.13 PharmaS
  74. 6.13.1 PharmaS Company Information
  75. 6.13.2 PharmaS Business Overview
  76. 6.13.3 PharmaS Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 PharmaS Tianeptine Product Portfolio
  78. 6.13.5 PharmaS Recent Developments
  79. 6.14 Serdia Pharmaceuticals
  80. 6.14.1 Serdia Pharmaceuticals Company Information
  81. 6.14.2 Serdia Pharmaceuticals Business Overview
  82. 6.14.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Serdia Pharmaceuticals Tianeptine Product Portfolio
  84. 6.14.5 Serdia Pharmaceuticals Recent Developments
  85. 6.15 Servier
  86. 6.15.1 Servier Company Information
  87. 6.15.2 Servier Business Overview
  88. 6.15.3 Servier Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Servier Tianeptine Product Portfolio
  90. 6.15.5 Servier Recent Developments
  91. 6.16 Mylan
  92. 6.16.1 Mylan Company Information
  93. 6.16.2 Mylan Business Overview
  94. 6.16.3 Mylan Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Mylan Tianeptine Product Portfolio
  96. 6.16.5 Mylan Recent Developments
  97. 6.17 Novartis
  98. 6.17.1 Novartis Company Information
  99. 6.17.2 Novartis Business Overview
  100. 6.17.3 Novartis Tianeptine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Novartis Tianeptine Product Portfolio
  102. 6.17.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Tianeptine Sales by Country
  2. 7.1.1 North America Tianeptine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tianeptine Sales by Country (2021-2026)
  4. 7.1.3 North America Tianeptine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tianeptine Market Size by Country
  6. 7.2.1 North America Tianeptine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tianeptine Market Size by Country (2021-2026)
  8. 7.2.3 North America Tianeptine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tianeptine Sales by Country
  2. 8.1.1 Europe Tianeptine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tianeptine Sales by Country (2021-2026)
  4. 8.1.3 Europe Tianeptine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tianeptine Market Size by Country
  6. 8.2.1 Europe Tianeptine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tianeptine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tianeptine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tianeptine Sales by Country
  2. 9.1.1 Asia-Pacific Tianeptine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tianeptine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tianeptine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tianeptine Market Size by Country
  6. 9.2.1 Asia-Pacific Tianeptine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tianeptine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tianeptine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tianeptine Sales by Country
  2. 10.1.1 South America Tianeptine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tianeptine Sales by Country (2021-2026)
  4. 10.1.3 South America Tianeptine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tianeptine Market Size by Country
  6. 10.2.1 South America Tianeptine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tianeptine Market Size by Country (2021-2026)
  8. 10.2.3 South America Tianeptine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tianeptine Sales by Country
  2. 11.1.1 Middle East and Africa Tianeptine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tianeptine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tianeptine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tianeptine Market Size by Country
  6. 11.2.1 Middle East and Africa Tianeptine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tianeptine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tianeptine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tianeptine Value Chain Analysis
  2. 12.1.1 Tianeptine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tianeptine Production Mode & Process
  7. 12.2 Tianeptine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tianeptine Distributors
  10. 12.2.3 Tianeptine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst